Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Why Do These Matter in CLL: Long-Term Data, Side-Effect Management, and Staying Healthy?

In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only, should never be considered medical advice, and should never be acted on without review with your health care team.

Recorded on April 28, 2022

Join CLL Society and PlatformQ Health for this on-demand educational session consisting of 3 chapters:

  • Getting Up-to-Speed on New Data
  • Managing Side Effects of BTK Inhibitors: What, When, How, and WhoTips to
  • Stay on the Patient/Caregiver ‘A Game’

Jennifer Woyach, MD, professor at The Ohio State University leads the discussion and is joined by a CLL Patient Advocate Therese Conlin. Real-world patient experiences frame discussions of what long-term research findings on BTK inhibitors and other treatments mean for patient quality of life. Registration is required before viewing the event.